Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024
Compare Balance Sheet Results of Emmessar Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
4.56
0.44
9.65%
Share Warrants & Outstandings
Total Reserve
2.71
10.72
-8.01
-74.72%
Shareholder's Funds
7.71
15.28
-7.57
-49.54%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.10
-0.10
-100.00%
Secured Loans
0.00
0.10
-0.10
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.32
0.42
-0.10
-23.81%
Other Long Term Liabilities
0.59
0.08
0.51
637.50%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.13
0.12
0.01
8.33%
Total Non-Current Liabilities
1.04
0.72
0.32
44.44%
Current Liabilities
Trade Payables
0.00
10.98
-10.98
-100.00%
Other Current Liabilities
0.13
0.16
-0.03
-18.75%
Short Term Borrowings
0.00
2.37
-2.37
-100.00%
Short Term Provisions
0.34
0.00
0.34
0.00%
Total Current Liabilities
0.47
13.50
-13.03
-96.52%
Total Liabilities
9.22
29.50
-20.28
-68.75%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.04
10.83
-8.79
-81.16%
Less: Accumulated Depreciation
0.82
6.68
-5.86
-87.72%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.22
4.16
-2.94
-70.67%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.59
0.04
0.55
1,375.00%
Long Term Loans & Advances
0.00
0.34
-0.34
-100.00%
Other Non Current Assets
0.00
0.92
-0.92
-100.00%
Total Non-Current Assets
1.81
5.46
-3.65
-66.85%
Current Assets Loans & Advances
Current Investments
0.01
0.00
0.01
0.00%
Inventories
0.12
9.41
-9.29
-98.72%
Sundry Debtors
0.02
9.49
-9.47
-99.79%
Cash and Bank
6.87
4.41
2.46
55.78%
Other Current Assets
0.09
0.01
0.08
800.00%
Short Term Loans and Advances
0.29
0.72
-0.43
-59.72%
Total Current Assets
7.41
24.04
-16.63
-69.18%
Net Current Assets (Including Current Investments)
6.93
10.54
-3.61
-34.25%
Total Current Assets Excluding Current Investments
7.40
24.04
-16.64
-69.22%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.22
29.50
-20.28
-68.75%
Contingent Liabilities
0.00
0.94
-0.94
-100.00%
Total Debt
0.00
2.47
-2.47
-100.00%
Book Value per share (adjusted)
15.43
15.65
-0.22
-1.41%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Annual - Investments
Investments 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Annual - Current Assets
Current Assets 7.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024






